Levetiracetam

Product NDC
66689-102
Requested package NDC
66689-102-20
11-digit product format
666890102
Labeler code
66689
Product ID
66689-102_c0232b95-ecd0-413d-a8ea-e6721aa21fdd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levetiracetam
Dosage form
SOLUTION
Route
ORAL
Labeler
VistaPharm, LLC
Application
ANDA078976
Marketing category
ANDA
Marketing start
2021-02-24
Marketing end
0000-00-00
Substance
LEVETIRACETAM
Active strength
100 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage66689-10266689-102-20DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078976-001LEVETIRACETAMLEVETIRACETAM100MG/MLSOLUTION / ORALAA2009-01-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A078976-001AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A078976-001LEVETIRACETAM100MG/MLSOLUTION / ORALAA2009-01-15a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A078976-001AA1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LevetiracetamLEVETIRACETAMActavis Pharma, Inc.5cb4a1db-f32d-44af-8985-0a94ca5064682024-05-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078976
application number: ANDA078976

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66689-102-01ML - Milliliter66689-102a2dc2901-e30a-412c-8001-5b2aa9f0b7a312021-04-08
66689-102-20ML - Milliliter66689-10255071b46-ce69-4f51-b5ae-11b8b2fbc50d12021-03-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LevetiracetamACTIVE INGREDIENT44YRR34555LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
LevetiracetamACTIVE MOIETY44YRR34555LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
acesulfame potassiumINACTIVE INGREDIENT23OV73Q5G9LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
citric acid monohydrateINACTIVE INGREDIENT2968PHW8QPLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
glycerinINACTIVE INGREDIENTPDC6A3C0OXLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
glycyrrhizin, ammoniatedINACTIVE INGREDIENT3VRD35U26CLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
maltitolINACTIVE INGREDIENTD65DG142WKLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
methylparabenINACTIVE INGREDIENTA2I8C7HI9TLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
propylparabenINACTIVE INGREDIENTZ8IX2SC1OHLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
trisodium citrate dihydrateINACTIVE INGREDIENTB22547B95KLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
waterINACTIVE INGREDIENT059QF0KO0RLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
66689-102-20666890102202 TRAY in 1 CASE (66689-102-20) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE (66689-102-01) 2 tray2021-02-240000-00-00NoNoCurrent